ASRS
SPRY icon

Arizona State Retirement System’s ARS Pharmaceuticals SPRY Stock Holding History

Arizona State Retirement System’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Sell
13,015
-1,915
-13% -$16.5K ﹤0.01% 2051
2026
Q1 		$120K Sell
14,930
-442
-3% -$4.24K ﹤0.01% 2001
2025
Q4 		$179K Buy
15,372
+2,299
+18% +$22.4K ﹤0.01% 1941
2025
Q3 		$131K Buy
13,073
+204
+2% +$2.93K ﹤0.01% 2040
2025
Q2 		$225K Buy
12,869
+1,760
+16% +$25.4K ﹤0.01% 1861
2025
Q1 		$140K Sell
11,109
-121
-1% -$1.46K ﹤0.01% 1966
2024
Q4 		$118K Buy
11,230
+70
+0.6% +$980 ﹤0.01% 2061
2024
Q3 		$162K Buy
+11,160
New +$133K ﹤0.01% 2018
2023
Q4 		– Sell
-10,794
Closed -$40.8K – 2191
2023
Q3 		$40.8K Buy
10,794
+188
+2% +$1.23K ﹤0.01% 2157
2023
Q2 		$71.1K Buy
+10,606
New +$70.8K ﹤0.01% 2153

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Arizona State Retirement System's SPRY Position: Q2 2026 in Review

Arizona State Retirement System reduced its ARS Pharmaceuticals (SPRY) stake by 13% in Q2 2026, selling an estimated $16.5K and leaving 13,015 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

Arizona State Retirement System first reported a position in SPRY in Q2 2023 and has held it in 10 quarters since. The position peaked at $225K in Q2 2025. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Arizona State Retirement System held 13,015 shares of ARS Pharmaceuticals worth $104K as of Q2 2026.
  • Arizona State Retirement System sold 1,915 ARS Pharmaceuticals shares in Q2 2026, an estimated $16.5K.
  • ARS Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #2051 holding.
  • Arizona State Retirement System first reported a position in ARS Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
  • Arizona State Retirement System's ARS Pharmaceuticals position peaked at $225K in Q2 2025.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.